Excited to share our latest work, now published in @NatureBiotech! We established the first prime editing platform for filamentous fungi, achieving average editing efficiencies approaching 90% across diverse loci and species. https://t.co/dgIhoIeiOH
Each year, we highlight companies that received sizeable early-stage funding in the previous year. Trogenix has developed a platform for generating ‘synthetic super-enhancers’ that could drive highly cell-specific gene therapy-based treatment of solid tumors such as glioblastoma https://t.co/Lqmcrvq0mD
A plug-and-play system fine-tunes multiple targets simultaneously for secondary metabolite production in Streptomyces https://t.co/Qtc9oH93Qw
https://t.co/1UsEa2Es7n
With endless curiosity and persistence, this biologist is motivated by the prospect of developing stem cell technologies that could one day repair damaged organs or even create new organs for transplantation https://t.co/wWQjJSKWL2
https://t.co/hQtPVxt54p
Mass spectrometry and wearable sensor technology are complementary approaches that, when integrated, can co-evolve to open new possibilities for noninvasive health monitoring https://t.co/QziLTr3SuT
https://t.co/O4IXsYDKw2
Research Briefing: Mapping the spatial landscape of extracellular vesicles in tissues with Spatial-EV-seq https://t.co/IVPOO9JUv4
https://t.co/tj98wlEVk5